“KASENSI” KADER SEHAT HIPERTENSI SEBAGAI UPAYA PENCEGAHAN COVID-19 PADA MASYARAKAT BERISIKO TINGGI

Main Article Content

Fiora Ladesvita
Diah Tika Anggraeni
Mareta Dea Rosaline

Abstract

Hypertensive patients were at high risk for exposure to COVID-19. Individuals with hypertension have a 2.5 times higher risk of suffering from severe COVID-19 and death than individuals without hypertension. One of the efforts that can be done was training for Health cadres and forming Hypertension Healthy Cadres during the pandemic. The approach taken is through the provision of training that begins with a pre-test to determine the level of knowledge and readiness to become a KASENSI COVID-19. After filling out the pre-test, training was carried out and also taught hypertension exercise to Cadres. After a series of training events, a post-test was given to determine and measure the final understanding. From the test results, it can be seen that the knowledge of Cadres increased by 6% after being given training related to KASENSI COVID-19 with p value 0.000 which means that the KASENSI COVID-19 training is effective in increasing the knowledge of Health cadres at Posbindu Dahlia Senja. As many as 15 out of 20 cadres said the material provided in the training was very useful and easy to apply to prevent COVID-19 infection in hypertensive patients, and 5 out of 20 cadres said hypertension exercise was very easy to do and taught to all hypertension sufferers during home visits by cadres. It is hoped that all cadres can carry out the main tasks and functions of KASENSI COVID-19 and play an active role in preventing exposure and reducing the risk of severity due to COVID-19 infection in sufferers with hypertension comorbid


ABSTRAK:

Pasien hipertensi sangat berisiko terhadap paparan COVID-19. Individu dengan hipertensi memiliki risiko 2,5 kali lebih tinggi untuk menderita COVID-19 yang parah dan mengalami kematian dibandingkan individu tanpa hipertensi. Salah satu upaya yang dapat dilakukan yaitu pelatihan terhadap kader kesehatan dan membentuk Kader Sehat Hipertensi di masa pandemi. Pendekatan yang dilakukan yaitu melalui pemberian pelatihan yang diawali dengan pre-test untuk mengetahui tingkat pengetahuan dan kesiapan untuk menjadi KASENSI COVID-19. Setelah mengisi pre-test, dilakukan pelatihan dan juga diajarkan senam hipertensi kepada kader.Setelah rangkaian acara pelatihan, diberikan post-testuntuk mengetahui dan mengukur pemahaman akhir. Hasil tes menunjukkan peningkatan pengetahuan kader sebesar 6% setelah diberikan pelatihan terkait KASENSI COVID-19 dengan p value 0,000 yang bermakna bahwa pelatihan KASENSI COVID-19 efektif dalam meningkatkan pengetahuan kader kesehatan di Posbindu Dahlia Senja. Sebanyak 15 dari 20 kader mengatakan materi yang diberikan dalam pelatihan sangat bermanfaat dan mudah diaplikasikan untuk mencegah infeksi COVID-19 pada pasien hipertensi, dan 5 dari 20 kader mengatakan senam hipertensi sangat mudah untuk dilakukan dan diajarkan ke seluruh penderita hipertensi pada saat kunjungan rumah oleh kader. Diharapkan seluruh kader dapat menjalankan tugas pokok dan fungsi KASENSI COVID-19 dan berperan aktif dalam mencegah paparan serta menurunkan resiko tingkat keparahan akibat infeksi COVID-19 pada masyarakat dengan komorbid hipertensi

Article Details

How to Cite
Ladesvita, F., Anggraeni, D. T., & Rosaline, M. D. (2021). “KASENSI” KADER SEHAT HIPERTENSI SEBAGAI UPAYA PENCEGAHAN COVID-19 PADA MASYARAKAT BERISIKO TINGGI. Jurnal Bakti Masyarakat Indonesia, 4(3). https://doi.org/10.24912/jbmi.v4i3.13537
Section
Articles

References

Daoust, J. F. (2020). Elderly people and responses to COVID-19 in 27 Countries. PloS One., 15(7), e0235590.

Dinas Kesehatan Jawa Barat. (2017). Profil Kesehatan Provinsi Jawa Barat Tahun 2017.

Fang, L., Karakiulakis, G., & Roth, M. (2020). Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection. The Lancet. Respiratory Medicine., 8(4), e21.

Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., & Müller, M. A. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell.

Kemenkes, R. I. (2018). Riset kesehatan dasar. Jakarta: Badan Penelitian dan Pengembangan Kesehatan.

Kunal, S., Gupta, K., Sharma, S. M., Pathak, V., Mittal, S., & Tarke, C. (2020). Cardiovascular system and COVID-19: perspectives from a developing country. Monaldi Arch. Chest Dis. 9(1), 231–241. doi: 10.4081/monaldi.2020.1305

Lippi, G., Wong, J., & Henry, B. M. (2020). Hypertension and its severity or mortality in Coronavirus Disease 2019 (COVID-19): a pooled analysis. Pol Arch Intern Med, 130(4), 304-309.

Schiffrin, E. L., Flack, J. M., Ito, S., Muntner, P., & Webb, R. C. (2020). Hypertension and COVID-19.

Tiksnadi, B. B., Sylviana, N., Cahyadi, A. I., & Undarsa, A. C. (2020). Olahraga Rutin Untuk Meningkatkan Imunitas Pasien Hipertensi Selama Masa Pandemi COVID-19. Indonesian Journal of Cardiology.

Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020). Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. Journal of virology, 94(7).

WHO. (2020). Diakses dari https://www.who.int/emergencies/diseases/novel-coronavirus-2019 pada tanggal 15 Juli 2020.

Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., et al. (2020). Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int. J. Infect. Dis., 9(4), 91–95. doi: 10.1016/j.ijid.2020. 03.017

Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., & Niu, P. (2020). China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med, 382(8), 727-733.